Jeffrey Radke Sells 95,223 Shares of Accelerant (NYSE:ARX) Stock

Accelerant Holdings (NYSE:ARX) CEO Jeffrey Radke sold 95,223 shares of the stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $14.60, for a total transaction of $1,390,255.80. Following the completion of the sale, the chief executive officer owned 27,751,939 shares of the company’s stock, valued at approximately $405,178,309.40. The trade was a 0.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Accelerant Trading Down 15.3%

Shares of NYSE:ARX opened at $12.47 on Thursday. The firm has a fifty day moving average of $14.00 and a two-hundred day moving average of $13.32. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17. Accelerant Holdings has a 12-month low of $9.18 and a 12-month high of $30.48. The firm has a market capitalization of $2.72 billion and a P/E ratio of -1.79.

Accelerant (NYSE:ARX) last posted its quarterly earnings results on Wednesday, May 13th. The technology company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Accelerant had a negative net margin of 135.47% and a positive return on equity of 49.99%. The business had revenue of $273.20 million for the quarter. The firm’s revenue was up 53.5% compared to the same quarter last year. On average, equities analysts expect that Accelerant Holdings will post 0.73 EPS for the current fiscal year.

Wall Street Analyst Weigh In

ARX has been the subject of a number of recent research reports. Citizens Jmp cut their price target on Accelerant from $20.00 to $17.00 and set a “market outperform” rating for the company in a research note on Monday, April 13th. Weiss Ratings cut Accelerant from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. UBS Group set a $16.00 price objective on Accelerant in a report on Thursday, May 21st. Piper Sandler lifted their target price on shares of Accelerant from $18.00 to $19.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. Finally, Raymond James Financial boosted their target price on shares of Accelerant from $16.00 to $19.00 and gave the stock an “outperform” rating in a research report on Monday, June 1st. Ten equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Accelerant presently has a consensus rating of “Moderate Buy” and a consensus target price of $18.60.

Trending Headlines about Accelerant

Here are the key news stories impacting Accelerant this week:

• Positive Sentiment: Analyst sentiment remains generally favorable. Ten analysts rate Accelerant a Buy, two rate it Hold and one rates it Sell; the consensus price target is $18.60, above recent trading levels. Raymond James and Piper Sandler have set $19 targets, while Wells Fargo maintains an Overweight rating with a $16 target. Accelerant insider trading and analyst coverage
• Positive Sentiment: The company’s latest reported quarter showed solid operating momentum: revenue increased 53.5% year over year to $273.2 million, while adjusted earnings of $0.17 per share exceeded expectations by $0.01. Institutional investors including Balyasny Asset Management, Azora Capital and JPMorgan also increased their positions, providing some support for the long-term investment case.
• Neutral Sentiment: COO Matthew David Sternberg sold 17,568 shares worth approximately $257,196 to cover tax-withholding obligations tied to vested equity awards. The sale was conducted under a pre-arranged Rule 10b5-1 plan, which reduces its value as a discretionary bearish signal. He retained 596,482 shares. Accelerant COO stock sale
• Negative Sentiment: Insider Francis James Oneill sold a combined 215,114 shares for approximately $3.14 million across July 27–28. The transactions reduced his ownership by about 3.2% in total, adding to concerns about insider monetization even though they were executed under a 10b5-1 plan. SEC filing for Oneill stock sales
• Negative Sentiment: CEO Jeffrey L. Radke separately sold 95,223 shares for about $1.39 million. Although the sale represented only 0.34% of his holdings and was prearranged, the combination of CEO, COO and other insider sales creates a near-term supply and sentiment overhang. SEC filing for CEO stock sale
• Negative Sentiment: Despite revenue growth and an earnings beat, Accelerant continues to report a deeply negative net margin and trades with a negative P/E ratio, highlighting ongoing profitability concerns. Recent target reductions from Morgan Stanley and Wells Fargo also temper the bullish analyst outlook.

Institutional Trading of Accelerant

Institutional investors and hedge funds have recently made changes to their positions in the stock. Envestnet Asset Management Inc. bought a new stake in shares of Accelerant during the 3rd quarter worth about $165,000. PNC Financial Services Group Inc. bought a new position in shares of Accelerant in the 3rd quarter valued at approximately $42,000. Vanguard Group Inc. acquired a new stake in Accelerant in the 3rd quarter worth approximately $33,482,000. Jefferies Financial Group Inc. acquired a new stake in Accelerant in the 3rd quarter worth approximately $149,000. Finally, Legal & General Group Plc bought a new stake in Accelerant during the third quarter worth approximately $149,000.

About Accelerant

Aeroflex Holding Corp. (Aeroflex Holding) is a provider of radio frequency (RF) and microwave integrated circuits, components and systems used in the design, development and maintenance of wireless communication systems. The Company’s solutions include microelectronic components and test and measurement equipment used by companies in the space, avionics and defense; commercial wireless communications, and medical and other markets. Its products include a range of RF, microwave and millimeter wave microelectronic components, integrated circuits (ICs), and analog and mixed-signal devices.